COSMIC project: consensus on the objectives of the metabolic syndrome in clinic
Juan Pedro-Botet,1 Juan F Ascaso,2,3 Vivencio Barrios,4,5 Alejandro De la Sierra,6 Javier Escalada,7,8 Jesús Millán,9 Jose M Mostaza,10 Pablo Pérez-Martínez,8,11 Xavier Pintó,8,12 Jordi Salas-Salvadó,8,13 Pedro Valdivielso14 1Lipids a...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-10-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity |
| Subjects: | |
| Online Access: | https://www.dovepress.com/cosmic-project-consensus-on-the-objectives-of-the-metabolic-syndrome-i-peer-reviewed-article-DMSO |
| _version_ | 1797712188197044224 |
|---|---|
| author | Pedro-Botet J Ascaso JF Barrios V De la Sierra A Escalada J Millán J Mostaza JM Pérez-Martínez P Pintó X Salas-Salvadó J Valdivielso P |
| author_facet | Pedro-Botet J Ascaso JF Barrios V De la Sierra A Escalada J Millán J Mostaza JM Pérez-Martínez P Pintó X Salas-Salvadó J Valdivielso P |
| author_sort | Pedro-Botet J |
| collection | DOAJ |
| description | Juan Pedro-Botet,1 Juan F Ascaso,2,3 Vivencio Barrios,4,5 Alejandro De la Sierra,6 Javier Escalada,7,8 Jesús Millán,9 Jose M Mostaza,10 Pablo Pérez-Martínez,8,11 Xavier Pintó,8,12 Jordi Salas-Salvadó,8,13 Pedro Valdivielso14 1Lipids and Vascular Risk Unit, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain; 2Endocrinology and Nutrition Service, Hospital Clínico, Universitat de Valencia, Valencia, Spain; 3INCLIVA Research Institute, Diabetes and Metabolic Diseases Ciber (Networked Biomedical Research Centres – CIBERDEM), Carlos III, Valencia, Spain; 4Cardiology Service, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain; 5Department of Medicine, Universidad Católica de Murcia (UCAM), Murcia, Spain; 6Internal Medicine Service, Hospital Mutua de Terrassa, Department of Medicine, Universidad de Barcelona, Spain; 7Department of Endocrinology and Nutrition, Clínica Universitaria de Navarra, IdiSNA; 8CIBEROBN “Physiopathology of Obesity and Nutrition”, Carlos III Health Institute, Spain; 9Lipid Unit, Department of Internal Medicine, Hospital Universitario General Gregorio Marañón, Universidad Complutense, Madrid, Spain; 10Lipid and Arteriosclerosis Unit, Internal Medicine Service, Hospital Carlos III, Madrid, Spain; 11Lipid and Arteriosclerosis Unit, Hospital Universitario Reina Sofía, IMIBIC/University of Cordoba, Cordoba, Spain; 12Lipids Unit, Department of Internal Medicine Hospital Universitario de Bellvitge, Universidad de Barcelona, Barcelona, Spain; 13Nutrition Unit, Hospital Universitari Sant Joan de Reus, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili; 14Internal Medicine Service, Department of Medicine and Dermatology, Hospital Universitario Virgen de la Victoria, Málaga Biomedicine Institute (IBIMA), Universidad de Málaga, Málaga, Spain Abstract: Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. Unfortunately, MetS is typically underrecognized, and there is great heterogeneity in its management, which can hamper clinical decision-making and be a barrier to achieving the therapeutic goals of CVD and diabetes prevention. Although no single treatment for MetS as a whole currently exists, management should be targeted at treating the conditions contributing to it and possibly reversing the risk factors. All this justifies the need to develop recommendations that adapt existing knowledge to clinical practice in our healthcare system. In this regard, professionals from different scientific societies who are involved in the management of the different MetS components reviewed the available scientific evidence focused basically on therapeutic aspects of MetS and developed a consensus document to establish recommendations on therapeutic goals that facilitate their homogenization in clinical decision-making. Keywords: cardiovascular prevention, diabetes prevention, insulin resistance, hypertension, dyslipidemia, obesity |
| first_indexed | 2024-03-12T07:18:06Z |
| format | Article |
| id | doaj.art-5122209c729d4503bf600cac6c085758 |
| institution | Directory Open Access Journal |
| issn | 1178-7007 |
| language | English |
| last_indexed | 2024-03-12T07:18:06Z |
| publishDate | 2018-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Diabetes, Metabolic Syndrome and Obesity |
| spelling | doaj.art-5122209c729d4503bf600cac6c0857582023-09-02T22:39:27ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072018-10-01Volume 1168369741927COSMIC project: consensus on the objectives of the metabolic syndrome in clinicPedro-Botet JAscaso JFBarrios VDe la Sierra AEscalada JMillán JMostaza JMPérez-Martínez PPintó XSalas-Salvadó JValdivielso PJuan Pedro-Botet,1 Juan F Ascaso,2,3 Vivencio Barrios,4,5 Alejandro De la Sierra,6 Javier Escalada,7,8 Jesús Millán,9 Jose M Mostaza,10 Pablo Pérez-Martínez,8,11 Xavier Pintó,8,12 Jordi Salas-Salvadó,8,13 Pedro Valdivielso14 1Lipids and Vascular Risk Unit, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain; 2Endocrinology and Nutrition Service, Hospital Clínico, Universitat de Valencia, Valencia, Spain; 3INCLIVA Research Institute, Diabetes and Metabolic Diseases Ciber (Networked Biomedical Research Centres – CIBERDEM), Carlos III, Valencia, Spain; 4Cardiology Service, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain; 5Department of Medicine, Universidad Católica de Murcia (UCAM), Murcia, Spain; 6Internal Medicine Service, Hospital Mutua de Terrassa, Department of Medicine, Universidad de Barcelona, Spain; 7Department of Endocrinology and Nutrition, Clínica Universitaria de Navarra, IdiSNA; 8CIBEROBN “Physiopathology of Obesity and Nutrition”, Carlos III Health Institute, Spain; 9Lipid Unit, Department of Internal Medicine, Hospital Universitario General Gregorio Marañón, Universidad Complutense, Madrid, Spain; 10Lipid and Arteriosclerosis Unit, Internal Medicine Service, Hospital Carlos III, Madrid, Spain; 11Lipid and Arteriosclerosis Unit, Hospital Universitario Reina Sofía, IMIBIC/University of Cordoba, Cordoba, Spain; 12Lipids Unit, Department of Internal Medicine Hospital Universitario de Bellvitge, Universidad de Barcelona, Barcelona, Spain; 13Nutrition Unit, Hospital Universitari Sant Joan de Reus, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili; 14Internal Medicine Service, Department of Medicine and Dermatology, Hospital Universitario Virgen de la Victoria, Málaga Biomedicine Institute (IBIMA), Universidad de Málaga, Málaga, Spain Abstract: Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. Unfortunately, MetS is typically underrecognized, and there is great heterogeneity in its management, which can hamper clinical decision-making and be a barrier to achieving the therapeutic goals of CVD and diabetes prevention. Although no single treatment for MetS as a whole currently exists, management should be targeted at treating the conditions contributing to it and possibly reversing the risk factors. All this justifies the need to develop recommendations that adapt existing knowledge to clinical practice in our healthcare system. In this regard, professionals from different scientific societies who are involved in the management of the different MetS components reviewed the available scientific evidence focused basically on therapeutic aspects of MetS and developed a consensus document to establish recommendations on therapeutic goals that facilitate their homogenization in clinical decision-making. Keywords: cardiovascular prevention, diabetes prevention, insulin resistance, hypertension, dyslipidemia, obesityhttps://www.dovepress.com/cosmic-project-consensus-on-the-objectives-of-the-metabolic-syndrome-i-peer-reviewed-article-DMSOcardiovascular preventiondiabetes preventioninsulin resistancemetabolic syndromeobesity. |
| spellingShingle | Pedro-Botet J Ascaso JF Barrios V De la Sierra A Escalada J Millán J Mostaza JM Pérez-Martínez P Pintó X Salas-Salvadó J Valdivielso P COSMIC project: consensus on the objectives of the metabolic syndrome in clinic Diabetes, Metabolic Syndrome and Obesity cardiovascular prevention diabetes prevention insulin resistance metabolic syndrome obesity. |
| title | COSMIC project: consensus on the objectives of the metabolic syndrome in clinic |
| title_full | COSMIC project: consensus on the objectives of the metabolic syndrome in clinic |
| title_fullStr | COSMIC project: consensus on the objectives of the metabolic syndrome in clinic |
| title_full_unstemmed | COSMIC project: consensus on the objectives of the metabolic syndrome in clinic |
| title_short | COSMIC project: consensus on the objectives of the metabolic syndrome in clinic |
| title_sort | cosmic project consensus on the objectives of the metabolic syndrome in clinic |
| topic | cardiovascular prevention diabetes prevention insulin resistance metabolic syndrome obesity. |
| url | https://www.dovepress.com/cosmic-project-consensus-on-the-objectives-of-the-metabolic-syndrome-i-peer-reviewed-article-DMSO |
| work_keys_str_mv | AT pedrobotetj cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT ascasojf cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT barriosv cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT delasierraa cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT escaladaj cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT millanj cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT mostazajm cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT perezmartinezp cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT pintox cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT salassalvadoj cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic AT valdivielsop cosmicprojectconsensusontheobjectivesofthemetabolicsyndromeinclinic |